SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Typen is Crynode's first MVP AI Agent designed to interact with both people and other AI agents. It leverages a combination of state-of-the-art AI models and advanced machine learning techniques to think, analyze, and navigate the Solana blockchain. Typen’s architecture is custom-built and advanced, setting it apart from starter frameworks like Eliza (ai16z), as shown by the depth of his responses. He’s built for head-to-head competition with shallow AIs like $goat (Terminal of Truths), aiming to provide real value rather than just entertainment. Typen represents the first pillar of Crynode's long-term vision: a future where high-quality AIs cooperate with humans to create sustainable, long-term wealth.

Typen

Typen ($TYPEN) is trending, with community members highlighting its availability on Phantom Wallet and anticipating a potential breakout. The crypto is generating buzz as traders discuss its strong momentum and potential for significant growth within the Solana ecosystem. Many are watching for it to potentially "moon".

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community celebrates its recent listing on CoinMarketCap, viewing it as a major milestone. Discussions revolve around the project's mission-driven approach and strong community, with many expressing long-term conviction. The listing comes amid broader conversations about the $SOL ecosystem and the potential for alt season.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is experiencing a pump, leading to community excitement about potential gains and comparisons to other privacy coins like ZEC. Some speculate on the reasons behind the price movement, noting DASH's low supply and potential for being "crash resistant". The community is watching for a breakout above certain price levels, with some anticipating a move to $100.

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Estee Lauder Cos., Inc. - Ordinary Shares - Class A

Estee Lauder Cos. Inc

Estee Lauder ($EL) is trending amid discussions of potential retail squeeze and unusual options activity, with high call option volume. Community members are actively sharing potential entry and exit points for options trades, while some express concerns about the company's exposure to China and restructuring plans. Bullish sentiment is fueled by potential ROI on call options, while others watch for pullbacks and key price levels.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion Inc is trending due to community discussion around its low float and potential for a significant price increase, with some anticipating a short squeeze. However, some investors are wary due to the company's history of reverse stock splits and dilution, suggesting potential risks. Others highlight potential revenue opportunities and suggest that it is undervalued.

Consolidated Edison, Inc. is a holding company, which engages in the business of regulated electric, gas, and steam delivery. It operates through the following segments: Consolidated Edison Company of New York (CECONY), Orange and Rockland Utilities(O&R), and Con Edison Transmission. The CECONY segment is involved in the regulated electric, gas, and steam utility businesses. The O&R segment covers regulated electric and gas utility delivery businesses. The Con Edison Transmission segment invests in electric and gas transmission projects. The company was founded in 1823 and is headquartered in New York, NY.

Consolidated Edison, Inc.

Recent option volume suggests increased interest in $ED, particularly in call options, with some traders targeting specific prices and expiration dates. Community discussion includes speculation on potential upside, with some highlighting the company's investments and dividend history, while others note factors such as regulatory challenges and analyst ratings.

Diamondback Energy, Inc. is an independent oil and natural gas company, which engages in the acquisition, development, exploration, and exploitation of unconventional, onshore oil, and natural gas reserves. It operates through the Upstream and Midstream Services segments. The Upstream segment focuses on the Permian Basin operations in West Texas. The Midstream Services segment is involved in the Midland and Delaware Basins. The company was founded in December 2007 and is headquartered in Midland, TX.

Diamondback Energy Inc

Diamondback Energy is trending as options activity and analyst ratings are being updated. Community members are actively discussing potential upside and long-term investment strategies, as well as production in the Permian Basin. Some investors are also concerned about the recent decline in share price and overall market volatility.

Zoracles

ZORA is trending following its listing on Robinhood, with community members actively discussing the potential impact of increased exposure and new users. Many believe this listing could lead to significant gains, highlighting the coin's utility for content creators and its potential for widespread adoption. However, some traders are wary of a potential pump and dump, urging caution amid the excitement.

Anoma is the decentralized OS powering a unified app layer for all Web3. With Anoma, developers can write one app that works on any chain. Anoma frees developers from the complexity of infrastructure so they can focus on what matters: building apps and experiences that people love. Anoma introduces a next-gen intent-centric architecture optimized for app development and UX, enabling Web3 to support a rich ecosystem of apps that can finally compete with the functionality and experience of Web2.

Anoma

Anoma (XAN) is trending as the crypto community debates its recent price volatility and potential for recovery. Discussions center around whether recent airdrops are impacting the token's value, while some investors express optimism about a potential rebound and long-term prospects, others cite concerns about tokenomics.

CyberArk Software Ltd. engages in the development, market, and sale of access security software solutions. The firm's products include Privilege, Access, and DevSecOps. It offers its products and services to banking, insurance, healthcare, and federal industries. The company was founded by Udi Mokady and Alon Cohen in 1999 and is headquartered in Petah Tikva, Israel.

CyberArk Software Ltd

CyberArk Software is trending as community members discuss its potential as a retail squeeze play and highlight unusual options activity, particularly bullish call flow. Comparisons to peers in the cybersecurity sector, like Palo Alto Networks, are circulating, alongside mentions of AI and cloud leverage. Discussions also touch upon recent analyst rating adjustments and price target updates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RVVTF who else suspects that Dr Kizilbash and Delta Health have been incentivized with shares or options for Revive to get the trial completed. Given Dr Kizilbash’s experience with Revive, he may have even told MF, I can get it done in Turkey faster, if you make it worth my while… just a thought.

Chris john

skee

Ryan Bird

LittleYellowDuck

Gary Berenda

Bob Hope

StockTwits for iOS

Revive Therapeutics Ltd

 who else suspects that Dr Kizilbash and Delta Health have been incentivized with shares or options for Revive to get the trial completed. Given Dr Kizilbash’s experience with Revive, he may have even told MF, I can get it done in Turkey faster, if you make it worth my while… just a thought.

@StuBeef https://www.reddit.com/r/RVVTF/comments/s3id9t/great_question_any_answers_bmt/?utm_source=share&amp;utm_medium=ios_app&amp;utm_name=iossmf

bdizzle69

David

Sort posts by "Hot" to participate in the RVV Lounge.* A life science company focused on the research and development of therapeutics for rare disorders and infectious diseases. $RVV.CN $RVVTF Investment information & DD for Revive Therapeutics https://revivethera.com/ *We are not part of the Revive Therapeutics team*

reddit

Great question. Any answers? BMT?

@StuBeef unfounded speculation. Not saying it isn&#39;t possible, but this is approaching tinfoil territory given current info

StockTwits For Android 

 unfounded speculation. Not saying it isn't possible, but this is approaching tinfoil territory given current info

Kyle Eller

@ellerk88 lol, no doubt! I’m in deep here with a lot of my SAVA profits. I keep thinking if MF gave lobbyists and other players incentive shares, why not do the same with Delta. I mean if I were in his position, I certainly would.

 lol, no doubt! I’m in deep here with a lot of my SAVA profits. I keep thinking if MF gave lobbyists and other players incentive shares, why not do the same with Delta. I mean if I were in his position, I certainly would.

@StuBeef @ellerk88 lead or active member of a trial is much different. Calls for conflicts could be rampant with that sort of move. For everything MF has done up to this point, sacrificing the integrity of the trial has NOT been one of those

 @ellerk88 lead or active member of a trial is much different. Calls for conflicts could be rampant with that sort of move. For everything MF has done up to this point, sacrificing the integrity of the trial has NOT been one of those

@ellerk88 fair point. But surely with it being blinded, there is no danger of integrity of the trial. Motivating a trial site to get more patients to be evaluated for enrollment surely isn’t a conflict of interest?

 fair point. But surely with it being blinded, there is no danger of integrity of the trial. Motivating a trial site to get more patients to be evaluated for enrollment surely isn’t a conflict of interest?

@StuBeef @ellerk88 blinded does not matter when you have inclusion/exclusion criteria for the sample. The director in some form or capacity could be swayed in enrolling patients who might not fit all criteria if given some type of equity compensation. This is not a valid practice in research and would cast a MAJOR cloud on the trial.

 @ellerk88 blinded does not matter when you have inclusion/exclusion criteria for the sample. The director in some form or capacity could be swayed in enrolling patients who might not fit all criteria if given some type of equity compensation. This is not a valid practice in research and would cast a MAJOR cloud on the trial.

@ellerk88 thanks for sharing that perspective! So we just hope that fewer vaccinated and overall larger pool of patients means we will get more eligible patients for enrollment.

 thanks for sharing that perspective! So we just hope that fewer vaccinated and overall larger pool of patients means we will get more eligible patients for enrollment.

@StuBeef @ellerk88 additional point,, vaccination is not part of the inclusion/exclusion criteria according to the trial site

Mh_floorz

 @ellerk88 additional point,, vaccination is not part of the inclusion/exclusion criteria according to the trial site